<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT00270517</url>
  </required_header>
  <id_info>
    <org_study_id>EDP420-05-006</org_study_id>
    <nct_id>NCT00270517</nct_id>
  </id_info>
  <brief_title>Comparative Study of EDP-420 Versus Another Antibiotic in the Treatment of Community Acquired Pneumonia</brief_title>
  <official_title>A Randomized, Double-Blinded, Parallel Group, Multicenter Study of EDP-420 Versus Telithromycin for the Treatment of Community Acquired Pneumonia</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Enanta Pharmaceuticals</agency>
      <agency_class>Industry</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Enanta Pharmaceuticals</source>
  <brief_summary>
    <textblock>
      This study will compare the efficacy, safety and tolerability of EDP-420 versus another oral
      antibiotic in the treatment of community acquired pneumonia
    </textblock>
  </brief_summary>
  <overall_status>Unknown status</overall_status>
  <last_known_status>Recruiting</last_known_status>
  <start_date>December 2005</start_date>
  <completion_date>July 2007</completion_date>
  <phase>Phase 2</phase>
  <study_type>Interventional</study_type>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Double</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Clinical Cure 7-14 days after end of therapy</measure>
  </primary_outcome>
  <secondary_outcome>
    <measure>Bacteriological response</measure>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Radiographic response</measure>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Change in signs and symptoms</measure>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Safety</measure>
  </secondary_outcome>
  <enrollment>250</enrollment>
  <condition>Community Acquired Pneumonia</condition>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>EDP-420 / Duration of Treatment – 3 days</intervention_name>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Telithromycin / Duration of Treatment – 7 days</intervention_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Recent respiratory illness with signs and symptoms and chest X-ray consistent with the
             diagnosis of community-acquired pneumonia.

          -  Suitable candidate for oral antibiotic therapy and able to swallow large capsules
             intact

          -  If female, must be non-lactating and at no risk for pregnancy

        Exclusion Criteria:

          -  Other infections

          -  Other pulmonary diseases requirement multiple antibacterial medications or long
             duration of therapy

          -  History of hypersensitivity, allergic or adverse reactions to macrolide, ketolide,
             azalide or streptogramins

          -  Evidence of uncontrolled clinically significant disease, malignancy, or other
             abnormality

          -  Requirement of parenteral antimicrobial therapy for treatment of pneumonia

          -  Currently receiving or likely to receive any known inhibitors or inducers of
             cytochrome P450 mediated drug metabolism

          -  Immunocompromised subjects
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>65 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Study Director</last_name>
    <role>Study Director</role>
    <affiliation>Enanta Pharmaceuticals, Inc</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Medical Director</last_name>
    <email>clinical@enanta.com</email>
  </overall_contact>
  <location>
    <facility>
      <name>Enanta Pharmaceuticals, Inc.</name>
      <address>
        <city>Watertown</city>
        <state>Massachusetts</state>
        <zip>02472</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Study Director</last_name>
      <email>clinical@enanta.com</email>
    </contact>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>September 2006</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>December 23, 2005</study_first_submitted>
  <study_first_submitted_qc>December 23, 2005</study_first_submitted_qc>
  <study_first_posted type="Estimate">December 28, 2005</study_first_posted>
  <last_update_submitted>September 18, 2006</last_update_submitted>
  <last_update_submitted_qc>September 18, 2006</last_update_submitted_qc>
  <last_update_posted type="Estimate">September 19, 2006</last_update_posted>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Pneumonia</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Telithromycin</mesh_term>
  </intervention_browse>
  <pending_results>
    <submitted>February 17, 2010</submitted>
    <submission_canceled>Unknown</submission_canceled>
    <submitted>February 11, 2014</submitted>
    <submission_canceled>Unknown</submission_canceled>
  </pending_results>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

